Rehabilitation of a patient with critical illness polyneuropathy (CIP) following acute respiratory failure: A case report and review of literature

Disability and Rehabilitation

Volumn 25, Issue 6, 2003, Pages 273-276

  Aichenbaum, S R ^a   Ring, H ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; NEUROMUSCULAR BLOCKING AGENT; PREDNISONE;

ACUTE RESPIRATORY FAILURE; ADULT; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BRAIN INFARCTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; CRITICAL ILLNESS; DISEASE ASSOCIATION; DYSPHONIA; FUNCTIONAL ASSESSMENT; HEMIPARESIS; HOSPITAL DISCHARGE; HUMAN; MALE; MEDICAL LITERATURE; NERVE FIBER DEGENERATION; OCCUPATIONAL THERAPY; OUTCOMES RESEARCH; PATIENT REFERRAL; PHYSIOTHERAPY; PNEUMONIA; POLYNEUROPATHY; PRIORITY JOURNAL; REHABILITATION CENTER; REHABILITATION MEDICINE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SPEECH THERAPY; STROKE;

ACUTE DISEASE; CRITICAL ILLNESS; FOLLOW-UP STUDIES; HUMANS; ISRAEL; MALE; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; POLYNEUROPATHIES; QUALITY OF LIFE; REHABILITATION CENTERS; RESPIRATORY DISTRESS SYNDROME, ADULT; TRACHEOTOMY; TREATMENT OUTCOME;

EID: 0037452840     PISSN: 09638288     EISSN: None     Source Type: Journal    
DOI: 10.1080/0963828021000031214     Document Type: Article

References (24)

1. Kennedy DD, Fletcher N, Hinds Ch. Neuromuscular dysfunction in critical illness: what are we dealing with? Current Opinion in Anaesthesiology 2000; 13(2): 93-98.
2. Eriksson LI. Critical illness polyneuropathy and myopathy. Acta Anaesthesiologica Scandinavica 2001; 45: Suppl. 115: 46.
3. Van-der-Schaaf M, Beelen A, de-Groot IJ. Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome. Disability and Rehabilitation 2000; 22(17): 808-810.
4. Jarrett SR, Mogelof JS. Critical illness neuropathy: diagnosis and management. Archives of Physical Medicine and Rehabilitation 1995; 76(7): 688-691.
5. Nagaratnam N, Jamieson G, Chiu K, Ramos C. Critical illness neuropathy. Neurorehabilitation and Neural Repair 2001; 15: 81-84.
6. Karlsen B, Vedeler CA. Neuromuscular complications of sepsis. Tidsskrift for den Norske laegeforening (Norwegian) 2001; 121(7): 799-801.
7. Lacomis D, Petrella JT, Giuliani MJ. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle and Nerve 1998; 21(5): 610-617.
8. Sharabi Y, Segal E, Grossman E. Prolonged neuromuscular damage following corticosteroids and muscle relaxants. Harefuah (Hebrew) 2000; 138(12): 1030-1032.
9. Mouallem M, Adunsky A, Semo H, Dolgopiat M. Polyneuropathy in critical illness. Harefuah (Hebrew) 1999; 136(9): 686-689.
10. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Annals of Neurology 1993; 33: 94-100.
11. Deconinck N, Van Parijs V, Beckers Bleukx G, Van den Bergh P. Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscular Disorders 1998; 8(3-4): 186-192.
12. Larsson L, Li X, Edstrom L, Eriksson LI, Zackrisson H, Argentini C, Schiaffino S. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Critical Care Medicine 2000; 28(1): 34-45.
13. Latronico, Guarneri B, Alongi S, Bussi G, Candiani A. Acute neuromuscular respiratory failure after ICU discharge: Report of five patients. Intensive Care Medicine 1999; 25(11): 1302-1306.
14. Isner-Horobeti ME, Lecocq J, Vautravers P, Kummerlen C. Polyneuropathy and neuromyopathy in intensive care. 4 new cases. Revue neurologique (Paris) 1998; 154(11): 767-770.
15. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia J-L, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, Garnacho-Montero M-C, Moyano-Del-Estad M-R. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Medicine 2001; 27(8): 1288-1296.
16. Hund E. Critical illness polyneuropathy. Current Opinion in Neurology 2001; 14(5): 649-653.
17. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Critical Care Medicine 1996; 24: 1408-1416.
18. de Letter MACJ, van Doorn PA, Savelkoul HFJ et al. Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. Journal of Neuroimmunology 2000; 106: 206-213.
19. Hinshaw LB. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Critical Care Medicine 1996; 24: 1072-1078.
20. Hund E, Herkert M, Becker C-M, Hacke W. A humoral neurotoxic factor in sera of patients with critical illness polyneuropathy. Annals of Neurology 1996; 40: 539.
21. Druschky A, Herkert M, Radespiel-Troger, Druschky, Hund E, Becker CM, Hilz MJ, Erbguth F, Neundorfer B. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Medicine 2001; 27(4): 686-693.
22. Leijten FSS, Harinck-de Weerd JE, Poortvliet DCJ, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. Journal of the American Medical Association 1995; 274: 1221-1225.
23. Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve 2000; suppl 9: S49-S52.
24. de Seze M, Petit H, Wiart L, Cardinaud JP, Gaujard E, Joseph PA, Mazaux JM, Barat M. Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. European neurology 2000; 43(2): 61-69.